Basit öğe kaydını göster

dc.contributor.authorBasarir, Gunce
dc.contributor.authorOzcabi, Bahar
dc.contributor.authorSayman, Ozden Aksu
dc.contributor.authorAkay, Hatice Ozturkmen
dc.contributor.authorYildiz, Feyza M.
dc.date.accessioned2022-08-16T11:29:22Z
dc.date.available2022-08-16T11:29:22Z
dc.date.issued2021
dc.identifier.issn0334-018Xen_US
dc.identifier.urihttp://hdl.handle.net/11727/7369
dc.description.abstractObjectives: Non-alcoholic fatty liver disease (NAFLD) is a common obesity-related comorbidity in childhood. In this study, we aimed to evaluate predictors of NAFLD by comparing clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis. Methods: Two hundred and eight obese children aged 6-18 years were included. The patients were divided into group 1 (patients with NAFLD, n=94) and group 2 (patients without NAFLD, n=114). Anthropometric measurements, pubertal stage, lipid profiles, fasting glucose and insulin, homeostatic model of assessment for insulin resistance (HOMA-IR), uric acid, total bilirubin, alanine aminotransferase (ALT), blood urea nitrogen, thyroid-stimulating hormone and free thyroxine parameters were compared retrospectively. Results: The mean body weight, body mass index (BMI), height, tri-ponderal mass index (TMI), insulin, HOMA-IR, triglyceride, ALT and uric acid values were significantly higher, while high-density lipoprotein-cholesterol (HDL-C) values were significantly lower in group 1. The 70.7% of obese children with hepatosteatosis and 83.9% of those without hepatosteatosis were correctly estimated by parameters including age, gender, ALT, HDL-C, fasting insulin and uric acid values. Conclusions: Since obesity-associated hepatosteatosis induces various long-term metabolic impacts in children, early detection is of critical importance. Age, gender, TMI, BMI, ALT, HDL-C, fasting insulin and uric acid values may help to predict the risk of hepatosteatosis. Besides, we assessed whether TMI compared to BMI does not have a better utility in estimating obesity-induced hepatosteatosis in children. This is the first study to show the association between TMI and hepatosteatosis in children.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1515/jpem-2021-0034en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectchildhooden_US
dc.subjecthepatosteatosisen_US
dc.subjectnon-alcoholic fatty liver disease (NAFLD)en_US
dc.subjectobesityen_US
dc.subjecttri-ponderal mass index (TMI)en_US
dc.titleEvaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosisen_US
dc.typearticleen_US
dc.relation.journalJOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISMen_US
dc.identifier.volume34en_US
dc.identifier.issue9en_US
dc.identifier.startpage1081en_US
dc.identifier.endpage1087en_US
dc.identifier.wos000694009200002en_US
dc.identifier.scopus2-s2.0-85109047167en_US
dc.contributor.pubmedID34142516en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster